Article

Purwati, - and Budiono, - and Brian Eka Rachman, - and Yulistiani, - and Andang Miatmoko, - and Nasronudin, - and Soroy Lardo, - and Yongki Iswandi Purnama, - and Mafidhatul Laely, - and Ike Rochmad, - and Taufik Ismail, - and Sri Wulandari, - and Dwi Setyawan, - and Alfian Nur Rosyid, - and Herley Windo Setiawan, - and Prastuti Asta Wulaningrum, - and Tri Pudy Asmarawati, - and Erika Marfiani, - and Shinta Karina Yuniati, - and Muhammad Rabiul Fuadi, - and Pepy Dwi Endraswari, - and Purwaningsih, - and Eryk Hendrianto, - and Deya Karsari, - and Aristika Dinaryanti, - and Nora Ertanti, - and Igo Syaiful Ihsan, - and Disca Sandyakala Purnama, - and Yuni Indrayani, - (2021) A Randomized, Double-Blind, Multicenter Clinical Study Comparing the Efficacy and Safety of a Drug Combination of Lopinavir/Ritonavir-Azithromycin, Lopinavir/Ritonavir-Doxycycline, and Azithromycin-Hydroxychloroquine for Patients Diagnosed with Mild to Moderate COVID-19 Infections. Biochemistry Research International, 2021. pp. 1-12. ISSN 2090-2255